Blueprint Medicines Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	27,874	26,987	22,739	24,467	15,629
Revenue Growth (YoY)	24.50%	18.68%	-7.06%	56.55%	-
Cost of Revenue	23,863	22,882	18,517	19,565	13,095
Gross Profit	4,011	4,105	4,223	4,902	2,534
Selling, General & Admin	1,716	1,633	1,461	1,383	1,118
Research & Development	689.07	662.38	603.8	588.67	405
Operating Expenses	2,407	2,302	2,085	2,006	1,488
Operating Income	1,604	1,802	2,137	2,896	1,047
Interest Expense	-39.59	-46.38	-63.17	-88.6	-30.48
Interest & Investment Income	192.06	224.52	176.47	24.2	9.02
Currency Exchange Gain (Loss)	173.43	247.16	35.15	4.39	-10.82
Other Non Operating Income (Expenses)	117.46	117.16	66.55	75.07	58.33
EBT Excluding Unusual Items	2,053	2,345	2,352	2,911	1,073
Gain (Loss) on Sale of Investments	-	-	-	7.57	5.72
Gain (Loss) on Sale of Assets	-2.59	-1.4	-1.17	-2.24	2.7
Pretax Income	2,051	2,344	2,351	2,916	1,081
Income Tax Expense	420.04	522.51	384.33	563.16	241.65
Earnings From Continuing Operations	1,631	1,821	1,967	2,353	839.45
Minority Interest in Earnings	-78.35	-110.09	-70.12	-64.21	1.56
Net Income	1,552	1,711	1,897	2,289	841.01
Net Income to Common	1,552	1,711	1,897	2,289	841.01
Net Income Growth	-16.90%	-9.79%	-17.13%	172.13%	-
Shares Outstanding (Basic)	141	140	140	140	140
Shares Outstanding (Diluted)	142	141	141	140	140
Shares Change (YoY)	0.62%	-0.05%	0.44%	-	-
EPS (Basic)	10.99	12.22	13.55	16.35	6.01
EPS (Diluted)	10.95	12.17	13.49	16.35	6.01
EPS Growth	-17.50%	-9.79%	-17.48%	172.13%	-
Free Cash Flow	1,026	986.92	2,610	1,908	-783.6
Free Cash Flow Per Share	7.25	7.02	18.56	13.63	-5.60
Dividend Per Share	6.000	6.000	5.500	6.600	1.930
Dividend Growth	9.09%	9.09%	-16.67%	241.97%	-
Gross Margin	14.39%	15.21%	18.57%	20.03%	16.21%
Operating Margin	5.75%	6.68%	9.40%	11.83%	6.70%
Profit Margin	5.57%	6.34%	8.34%	9.35%	5.38%
Free Cash Flow Margin	3.68%	3.66%	11.48%	7.80%	-5.01%
EBITDA	2,077	2,272	2,615	3,331	1,422
EBITDA Margin	7.45%	8.42%	11.50%	13.61%	9.10%
D&A For EBITDA	472.47	469.65	477.98	435.33	375.09
EBIT	1,604	1,802	2,137	2,896	1,047
EBIT Margin	5.75%	6.68%	9.40%	11.83%	6.70%
Effective Tax Rate	20.48%	22.30%	16.35%	19.31%	22.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.